Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Diagnostic Performance of a Flexible Penile Monitoring System for ED

NCT: NCT07762469 · NOT_YET_RECRUITING

NCT IDNCT07762469
StatusNOT_YET_RECRUITING
Start Date2026-08-01
Completion2028-02-01
SponsorBin Xu (OTHER)
First posted
Last updated

Brief Summary

This study aims to evaluate the diagnostic performance of a novel intelligent flexible penile monitoring system for erectile dysfunction (ED). The current gold standard, RigiScan Plus, often causes discomfort and disrupts sleep due to its mechanical rings, leading to potential "first-night effect" biases. This research utilizes a prospective crossover design to compare the accuracy of the new flexible system with RigiScan in measuring peak rigidity and tumescence. A total of 60 participants (30 ED patients and 30 healthy volunteers) will be enrolled. The study expects to confirm that the flexible system provides highly accurate diagnostic data while significantly improving patient comfort and maintaining natural sleep structures.

Frequently Asked Questions

What is Diagnostic Performance of a Flexible Penile Monitoring System for ED?

Diagnostic Performance of a Flexible Penile Monitoring System for ED is a clinical trial registered under NCT07762469. Current status: NOT_YET_RECRUITING.

What is the status of NCT07762469?

The current status of NCT07762469 (Diagnostic Performance of a Flexible Penile Monitoring System for ED) is: NOT_YET_RECRUITING.

When did Diagnostic Performance of a Flexible Penile Monitoring System for ED start?

Diagnostic Performance of a Flexible Penile Monitoring System for ED started on 2026-08-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.